Asymptomatic cholesteryl ester storage disease in an adult controlled with simvastatin

Annals of Clinical Biochemistry

Volumn 34, Issue 4, 1997, Pages 433-436

  Iverson, S A ^a   Cairns, S R ^a   Ward, C P ^b   Fensom, A H ^b  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Blood; Cholesterol; Hypercholesterolaemia; Hyperlipidaemia; Liver disease; Low density lipoprotein

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTER STORAGE DISEASE; HUMAN; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL;

EID: 0030846444     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400418     Document Type: Article

References (9)

1. Assman G, Seedorf U. Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR, Beaudet AL, Sly WS and Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995: 2563-87
2. Scriver CR, Beaudet AL, Sly WS, Valle D. Summary table. In: Beaudet AL, Sly WS and Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995: 1-50
3. Anderson RA, Byrum RS, Coates PM, Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase locus in Wolman disease. Proc Natl Acad Sci USA 1994; 91: 2718-22
4. Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 1994; 20: 329-31
5. Aslanidis C, Ries S, Fehringer P, Buchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996; 33: 85-93
6. Kelly S, Bakhru-Kishore R. Fluorimetric assay of acid lipase in human leukocytes. Clin Chim Acta 1979; 97: 239-42
7. Ginsberg HN, Le NA, Short PM, Ramakrishnan R, Desnick RJ. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with Lovastatin. J Clin Invest 1987; 80: 1692-7
8. Kostner GM, Hadorn B, Roscher A, Zechner R. Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease. J Inher Metab Dis 1985; 8: 9-12
9. Yokoyama S, McCoy E. Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin. J Inher Metab Dis 1992; 15: 291-2